Metabolic profile association with white matter hyperintensity in patients with mild cognitive impairment
Armin Ariaei, Raziyeh Zamiri, Amirabbas Ghasemi, Bahareh Rezayani, Shayesteh Rezayani, Aylar Ezatpour, Narges Farshidi, Elham Asghari Sheikhi, Ali Roghanian, for the Alzheimer’s Disease Neuroimaging Initiative, for the Alzheimer's Disease Metabolomics Consortium · 2026
Read Metabolic profile association with white matter hyperintensity in patients with mild cognitive impairment by Armin Ariaei, Raziyeh Zamiri, Amirabbas Ghasemi, Bahareh Rezayani, Shayesteh Rezayani, Aylar Ezatpour, Narges Farshidi, Elham Asghari Sheikhi, Ali Roghanian, for the Alzheimer’s Disease Neuroimaging Initiative, for the Alzheimer's Disease Metabolomics Consortium (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13276425.txt.
Description
Armin Ariaei and colleagues study blood metabolites and white matter damage in people with mild cognitive impairment, in a 2026 paper. Bright spots on brain scans, called white matter hyperintensities, signal small-vessel injury tied to dementia risk. The team used data from the Alzheimer's Disease Neuroimaging Initiative with three years of follow-up.
Nearly two hundred participants spanned healthy ageing, mild impairment, and Alzheimer disease. Several metabolites, including methionine and glutamic acid, matched greater white matter damage. Others, such as tyrosine and histidine, matched less damage. The authors suggest that amino acids may be overused in impairment, leaving lower blood levels while by-products build up in the brain.
Catalog record
| CREATOR | Armin Ariaei, Raziyeh Zamiri, Amirabbas Ghasemi, Bahareh Rezayani, Shayesteh Rezayani, Aylar Ezatpour, Narges Farshidi, Elham Asghari Sheikhi, Ali Roghanian, for the Alzheimer’s Disease Neuroimaging Initiative, for the Alzheimer's Disease Metabolomics Consortium |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |